Tiago Pereira-da-Silva
Universidade Nova de Lisboa
RadiologySurgeryCardiologyRetrospective cohort studySinus rhythmNatriuretic peptideSacubitril, ValsartanSacubitrilValsartanAcute coronary syndromeHeart failureCoronary artery diseaseStentHeart transplantationAtrial fibrillationPercutaneous coronary interventionGenousConfidence intervalMedicineEjection fraction
37Publications
5H-index
81Citations
Publications 35
Newest
#1Tiago Pereira-da-Silva (NOVA: Universidade Nova de Lisboa)H-Index: 5
Last. Miguel Mota Carmo (NOVA: Universidade Nova de Lisboa)H-Index: 10
view all 8 authors...
Abstract Background and aims The role of inflammation in atherosclerosis development and expression in different arterial territories is unclear. Soluble CD40 ligand (sCD40L) mediates inflammation and atherogenesis. Through a systematic review and meta-analysis, we assessed whether sCD40L was dysregulated in stable atherosclerosis, irrespective of the diseased arterial territory, and whether this dysregulation differed according to the specific territory. Methods Systematic literature searches w...
Source
#2Patrícia Napoleão (IMM: Instituto de Medicina Molecular)H-Index: 8
Last. Miguel Mota Carmo (NOVA: Universidade Nova de Lisboa)H-Index: 10
view all 7 authors...
BACKGROUND Sacubitril/valsartan had its prognosis benefit confirmed in the PARADIGM-HF trial. However, data on cardiopulmonary exercise testing (CPET) changes with sacubitril-valsartan therapy are scarce. OBJECTIVE This study aimed to compare CPET parameters before and after sacubitril-valsartan therapy. METHODS Prospective evaluation of chronic heart failure (HF) patients with left ventricular ejection fraction ≤40% despite optimized standard of care therapy, who started sacubitril-valsartan th...
1 CitationsSource
AIMS: Myocardial work is a new transthoracic echocardiogram (TTE) parameter that enhances the information provided through left ventricular (LV) global longitudinal strain (GLS). Nothing is known about the impact of sacubitril/valsartan (LCZ696) therapy on myocardial work parameters. The aim of this study was to evaluate the effects of LCZ696 on LV myocardial work in heart failure patients. METHODS: Prospective evaluation of chronic heart failure patients with LV ejection fraction of 40% or less...
4 CitationsSource
BACKGROUND: Atrial fibrillation (AF) is associated with increased mortality in heart failure (HF) patients. OBJECTIVE: To evaluate whether the risk of AF patients can be precisely stratified by relation with cardiopulmonary exercise test (CPET) cut-offs for heart transplantation (HT) selection. METHODS: Prospective evaluation of 274 consecutive HF patients with left ventricular ejection fraction ≤ 40%. The primary endpoint was a composite of cardiac death or urgent HT in 1-year follow-up. The pr...
1 CitationsSource
Source
Source
Source
Source
1234
Close Researchers